The relationship between homologous recombination repair and the sensitivity of human epidermis to the size of daily doses over a 5-week course of breast radiotherapy

Clinical Cancer Research

Volumn 18, Issue 19, 2012, Pages 5479-5488

  Somaiah, Navita ^a,b   Yarnold, John ^b   Daley, Frances ^b   Pearson, Ann ^b   Gothard, Lone ^b   Rothkamm, Kai ^c   Helleday, Thomas ^d  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^c PUBLIC HEALTH ENGLAND   (United Kingdom)

^d KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BETA1 INTEGRIN; BRCA1 PROTEIN; BRCA2 PROTEIN; CYCLIN A; DOUBLE STRANDED DNA; KI 67 ANTIGEN; ONCOPROTEIN; PROTEIN 53BP1; PROTEIN P21; RAD51 PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BASEMENT MEMBRANE; BREAST BIOPSY; BREAST CANCER; CANCER RADIOTHERAPY; CELL CYCLE ARREST; CELL DENSITY; CLINICAL ARTICLE; CONTROLLED STUDY; DESQUAMATION; DNA REPAIR; EPIDERMIS; ERYTHEMA; FEMALE; HOMOLOGOUS RECOMBINATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PUNCH BIOPSY; RADIATION DOSE; S PHASE CELL CYCLE CHECKPOINT; SKIN BIOPSY; TREATMENT DURATION; TREATMENT RESPONSE;

BREAST; BREAST NEOPLASMS; CELL CYCLE CHECKPOINTS; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DNA BREAKS, DOUBLE-STRANDED; DNA DAMAGE; EPIDERMIS; FEMALE; HUMANS; MIDDLE AGED; RADIATION TOLERANCE; RECOMBINATIONAL DNA REPAIR;

EID: 84866936319     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-10-3297     Document Type: Article

References (41)

1. Turesson I,NymanJ, Holmberg E,Oden A. Prognostic factors for acute and late skin reactions in radiotherapy patients. Int J Radiat Oncol Biol Phys 1996;36:1065-75. (Pubitemid 27014492)
2. Thames HD, Bentzen SM, Turesson I, Overgaard M, van den Bogaert W. Fractionation parameters for human tissues and tumors. Int J Radiat Biol 1989;56:701-10. (Pubitemid 20002017)
3. Owen JR, Ashton A, Bliss JM, Homewood J, Harper C, Hanson J, et al. Effect of radiotherapy fraction size on tumour control in patients with early-stage breast cancer after local tumour excision: long-term results of a randomised trial. Lancet Oncol 2006;7:467-71. (Pubitemid 43779171)
4. Bentzen SM, Agrawal RK, Aird EG, Barrett JM, Barrett-Lee PJ, Bliss JM, et al. TheUKStandardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet Oncol 2008;9:331-41.
5. Whelan TJ, Pignol JP, Levine MN, Julian JA, Mackenzie R, Parpia S, et al. Long-term results of hypofractionated radiation therapy for breast cancer. N Engl J Med 2010;362:513-20.
6. Steel GG. The ESTRO Breur lecture. Cellular sensitivity to low doserate irradiation focuses the problem of tumour radioresistance. Radiother Oncol 1991;20:71-83.
7. Rothkamm K, Kruger I, Thompson LH, Lobrich M. Pathways of DNA double-strand break repair during the mammalian cell cycle. Mol Cell Biol 2003;23:5706 -15.
8. Saleh-Gohari N, Helleday T. Conservative homologous recombination preferentially repairs DNA double-strand breaks in the S phase of the cell cycle in human cells. Nucleic Acids Res 2004;32:3683-8. (Pubitemid 39157716)
9. Beucher A, Birraux J, Tchouandong L, Barton O, Shibata A, Conrad S, et al. ATM and Artemis promote homologous recombination of radi-ation- induced DNA double-strand breaks in G2. EMBO J 2009;28: 3413-27.
10. Hopewell JW, Nyman J, Turesson I. Time factor for acute tissue reactions following fractionated irradiation: a balance between repopulation and enhanced radiosensitivity. Int J Radiat Biol 2003;79: 513- 24.
11. Thacker J, Wilkinson RE. The genetic basis of cellular recovery from radiation damage: response of the radiosensitive irs lines to low-doserate irradiation. Radiat Res 1995;144:294-300.
12. Rothkamm K, Kuhne M, Jeggo PA, Lobrich M. Radiation-induced genomic rearrangements formed by nonhomologous end-joining of DNA double-strand breaks. Cancer Res 2001;61:3886-93. (Pubitemid 32720946)
13. Kruger I, Rothkamm K, Lobrich M. Enhanced fidelity for rejoining radiation-induced DNA double-strand breaks in the G2 phase of Chinese hamster ovary cells. Nucleic Acids Res 2004;32:2677-84. (Pubitemid 38885939)
14. Turesson I, Thames HD. Repair capacity and kinetics of human skin during fractionated radiotherapy: erythema, desquamation, and telangiectasia after 3 and 5 year's follow-up. Radiother Oncol 1989;15:169-88. (Pubitemid 19169532)
15. Turesson I, Bernefors R, Book M, Flogegard M, Hermansson I, Johansson KA, et al. Normal tissue response to low doses of radiotherapy assessed by molecular markers-a study of skin in patients treated for prostate cancer. Acta Oncol 2001;40:941-51. (Pubitemid 34098481)
16. Turesson I, Nyman J, Qvarnstrom F, Simonsson M, Book M, Hermansson I, et al. A low-dose hypersensitive keratinocyte loss in response to fractionated radiotherapy is associated with growth arrest and apoptosis. Radiother Oncol 2010;94:90-101.
17. Thompson LH, Schild D. Homologous recombinational repair of DNA ensures mammalian chromosome stability. Mutat Res 2001;477: 131-53. (Pubitemid 32480197)
18. Hoskin PJ, Sibtain A, Daley FM, Saunders MI, Wilson GD. The immunohistochemical assessment of hypoxia, vascularity and proliferation in bladder carcinoma. Radiother Oncol 2004;72:159-68. (Pubitemid 39024591)
19. Abbas T, Dutta A. p21 in cancer: intricate networks and multiple activities. Nat Rev Cancer 2009;9:400-14.
20. Jazayeri A, Falck J, Lukas C, Bartek J, Smith GC, Lukas J, et al. ATMand cell cycle-dependent regulation of ATR in response to DNA double-strand breaks. Nat Cell Biol 2006;8:37-45. (Pubitemid 43064795)
21. Yamamoto A, Taki T, Yagi H, Habu T, Yoshida K, Yoshimura Y, et al. Cell cycle-dependent expression of the mouse Rad51 gene in proliferating cells. Mol Gen Genet 1996;251:1 -12.
22. Willers H, Taghian AG, Luo CM, Treszezamsky A, Sgroi DC, Powell SN. Utility of DNA repair protein foci for the detection of putative BRCA1 pathway defects in breast cancer biopsies. Mol Cancer Res 2009;7: 1304- 9.
23. Graeser M, McCarthy A, Lord CJ, Savage K, Hills M, Salter J, et al. A marker of homologous recombination predicts pathologic complete response to neoadjuvant chemotherapy in primary breast cancer. Clin Cancer Res 2010;16:6159-68.
24. Wilson PF, Hinz JM, Urbin SS, Nham PB, Thompson LH. Influence of homologous recombinational repair on cell survival and chromosomal aberration induction during the cell cycle in gamma-irradiated CHO cells. DNA Repair (Amst) 2010;9:737-44.
25. Ambler CA, Maatta A. Epidermal stem cells: location, potential and contribution to cancer. J Pathol 2009;217:206-16.
26. Li A, Simmons PJ, Kaur P. Identification and isolation of candidate human keratinocyte stem cells based on cell surface phenotype. Proc Natl Acad Sci U S A 1998;95:3902-7. (Pubitemid 28173226)
27. Jensen UB, Lowell S, Watt FM. The spatial relationship between stem cells and their progeny in the basal layer of human epidermis: a new view based on whole-mount labelling and lineage analysis. Development 1999;126:2409-18. (Pubitemid 29299010)
28. Legg J, Jensen UB, Broad S, Leigh I, Watt FM. Role of melanoma chondroitin sulphate proteoglycan in patterning stem cells in human interfollicular epidermis. Development 2003;130:6049- 63.
29. Bauerschmidt C, Arrichiello C, Burdak-Rothkamm S,Woodcock M, Hill MA, Stevens DL, et al. Cohesin promotes the repair of ionizing radiation-induced DNA double-strand breaks in replicated chromatin. Nucleic Acids Res 2010;38:477-87.
30. Utsumi H, Elkind MM. Requirement for repair of DNA double-strand breaks by homologous recombination in split-dose recovery. Radiat Res 2001;155:680-6. (Pubitemid 32410934)
31. Schultz LB, Chehab NH, Malikzay A, Halazonetis TD. p53 binding protein 1 (53BP1) is an early participant in the cellular response to DNA double-strand breaks. J Cell Biol 2000;151:1381-90. (Pubitemid 32047588)
32. Rodier F, Coppe JP, Patil CK, Hoeijmakers WA, Munoz DP, Raza SR, et al. Persistent DNA damage signalling triggers senescenceassociated in flammatory cytokine secretion. Nat Cell Biol 2009;11: 973- 9.
33. Hewitt G, Jurk D, Marques FD, Correia-Melo C, Hardy T, Gackowska A, et al. Telomeres are favoured targets of a persistent DNA damage response in ageing and stress-induced senescence. Nat Commun 2012;3:708.
34. Supiot S, Shubbar S, Fleshner N, Warde P, Hersey K, Wallace K, et al. A phase I trial of pre-operative radiotherapy for prostate cancer: clinical and translational studies. Radiother Oncol 2008;88:53-60.
35. Bao S,WuQ, McLendon RE, Hao Y, Shi Q, Hjelmeland AB, et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 2006;444:756-60.
36. Rachidi W, Harfourche G, Lemaitre G, Amiot F, Vaigot P, Martin MT. Sensing radiosensitivity of human epidermal stem cells. Radiother Oncol 2007;83:267- 76.
37. Nam JM, Chung Y, Hsu HC, Park CC. Beta1 integrin targeting to enhance radiation therapy. Int J Radiat Biol 2009;85:923-8.
38. Cordes N, Meineke V. Integrin signalling and the cellular response to ionizing radiation. J Mol Histol 2004;35:327-37. (Pubitemid 40585318)
39. Cordes N, Meineke V. Cell adhesion-mediated radioresistance (CAMRR). Extracellular matrix-dependent improvement of cell survival in human tumor and normal cells in vitro. Strahlenther Onkol 2003;179: 337-44. (Pubitemid 36606025)
40. Flatt PM, Price JO, Shaw A, Pietenpol JA. Differential cell cycle checkpoint response in normal human keratinocytes and fibroblasts. Cell Growth Differ 1998;9:535-43. (Pubitemid 28345910)
41. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, Craig RW. Participation of p53 protein in the cellular response to DNA damage. Cancer Res 1991;51:6304-11.